Lower risk of multi-system inflammatory syndrome in children (MIS-C) with the omicron variant
Authors:
Open Access
- 7 October 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 27, 1-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Lower Risk of Multisystem Inflammatory Syndrome in Children With the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2Clinical Infectious Diseases, 2022
- Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron WaveJAMA Pediatrics, 2022
- The seroprevalence of SARS‐CoV ‐2‐specific antibodies in children, Australia, November 2020 – March 2021Medical Journal of Australia, 2022
- Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in IsraelJAMA, 2022
- Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort studyBMJ Open, 2021
- An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2The Pediatric Infectious Disease Journal, 2021
- Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious paediatric conditionsCommunicable Diseases Intelligence, 2021
- Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammationProceedings of the National Academy of Sciences, 2020